Crosswalk Therapeutics, Inc.

United States of America

Create a watch for Crosswalk Therapeutics, Inc.
Total IP 13
Total IP Rank # 119,438
IP Activity Score 2.1/5.0    16
IP Activity Rank # 52,603

Patents

Trademarks

12 0
0 0
1 0
0
 
Last Patent 2025 - Human alpha-galactosidase variants
First Patent 2015 - Human alpha-galactosidase variants

Latest Inventions, Goods, Services

2025 Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galact...
2024 Invention Human alpha-galactosidase variants. Engineered human alpha-galactosidase polypeptides and compos...
Invention Engineered acid alpha-glucosidase variants. The present disclosure provides engineered acid alpha...
Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galacto...
Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha...
2020 Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha-...